Impact of Early Changes in Serum Biomarkers Following Androgen Deprivation Therapy on Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer

Hiromi Sato,Shintaro Narita,Norihiko Tsuchiya,Atsushi Koizumi,Taketoshi Nara,Sohei Kanda,Kazuyuki Numakura,Hiroshi Tsuruta,Atsushi Maeno,Mitsuru Saito,Takamitsu Inoue,Shigeru Satoh,Kyoko Nomura,Tomonori Habuchi

BMC urology（2018）

引用 10|浏览15

暂无评分

摘要

Less evidence is known about the role of early changes in serum biomarker after androgen deprivation therapy (ADT) in patients with metastatic hormone-sensitive prostate cancer (mHSPC). Here we evaluated the impact of pre-treatment prognostic factors and early changes in serum biomarkers on prostate specific antigen (PSA) progression-free and overall survival rates in mHSPC.

查看译文

关键词

Metastatic Hormone-sensitive Prostate Cancer,Serum Biomarkers,Androgen Deprivation Therapy,Early Changes,Prostate-specific Antigen (PSA)

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要